查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869882

足底筋膜炎治療市場規模、佔有率和趨勢分析報告：按藥物類別、疾病類型、最終用途、地區和細分市場預測（2025-2033 年）

Plantar Fasciitis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids), By Disease Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

足底筋膜炎治療市場摘要

2024年全球足底筋膜炎治療市場規模估計為12.8億美元，預計2033年將達到34.5億美元。

預計從 2025 年到 2033 年，該市場將以 11.9% 的複合年成長率成長。推動這一市場成長的主要因素包括肥胖症的增加、人口老化，以及由於長時間站立工作和高強度活動而導致的腳跟和腳部壓力增加。

意識提升、專業護理服務的可及性提高以及先進治療方法的引入，正進一步推動市場擴張。醫院、診所和門診機構越來越重視足部疾病的早期診斷和有效治療。這些因素共同推動了對治療性介入的需求，從而促進了足跟和足部護理領域的持續成長和創新。

儘管各國政府很少公佈準確的全球病例數，但據估計，每年約有100萬人次因足底筋膜炎就診。研究表明，約10%的人口在其一生中的某個階段會患上足底筋膜炎，其中83%為25至65歲的勞動年齡人口。據報道，跑步者的盛行率高達22%。

影像引導治療、超音波導引注射以及微創機械和聲學療法的進步，使得治療定位更加精準，恢復時間更短，療效更佳，從而提高了醫生和患者的接受度。 2025年7月發表於《美國物理醫學與復健學會雜誌》的一項研究比較了富血小板血漿（PRP）和皮質類固醇治療足底筋膜炎的療效。結果表明，與皮質類固醇注射相比，PRP能更有效地緩解疼痛並改善足部功能。同樣在2025年7月，勒克瑙國王喬治醫科大學的研究人員研究了超音波導引葡萄糖增強療法和PRP注射治療慢性足跟痛的療效。研究發現，兩種治療方法均能顯著減輕疼痛並改善足部功能，其中PRP的效果略勝一籌。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 足底筋膜炎治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析

第4章 足底筋膜炎治療市場：藥物類別商業分析

  • 按藥物類別分類的市場佔有率，2024 年和 2033 年
  • 藥物類別細分儀表板
  • 按藥物類別分類的市場規模、預測和趨勢分析，2021-2033年
  • 非類固醇消炎劑（NSAIDs）
  • 皮質類固醇
  • 其他

第5章 足底筋膜炎治療市場：疾病類型商業分析

  • 按疾病類型分類的市場佔有率，2024 年和 2033 年
  • 疾病類型細分儀表板
  • 按疾病類型分類的市場規模、預測和趨勢分析，2021-2033年
  • 急性足底筋膜炎
  • 慢性足底筋膜炎
  • 其他

第6章 足底筋膜炎治療市場：終端用戶業務分析

  • 按最終用途分類的市場佔有率，2024 年和 2033 年
  • 最終用戶細分儀表板
  • 按最終用途分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 醫院和診所
  • 門診手術中心
  • 其他

第7章 足底筋膜炎治療市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 按國家/地區分類，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2021-2033 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 按國家/地區分類，2021-2033 年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 按國家/地區分類，2021-2033 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區分類，2021-2033 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介
    • Pfizer Inc.
    • Bayer AG
    • Johnson &Johnson
    • Viatris Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • AbbVie Inc.
    • GSK plc.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-780-9

Plantar Fasciitis Treatment Market Summary

The global plantar fasciitis treatment market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 3.45 billion by 2033, growing at a CAGR of 11.9% from 2025 to 2033. The market growth is driven by rising prevalence of obesity, an aging population, and an increase in heel and foot strain cases caused by prolonged standing or high-impact activities.

Increasing awareness among patients about foot health, better access to specialized care, and the adoption of advanced treatment options are further supporting market expansion. Hospitals, clinics, and outpatient facilities are emphasizing early diagnosis and effective management of foot-related conditions. Combined, these factors are fueling demand for therapeutic interventions, driving consistent growth and encouraging innovation within the heel and foot care segment.

Although governments rarely provide exact global case figures, estimates suggest that approximately 1 million patient visits yearly are due to plantar fasciitis. Research indicates that around 10% of the population experience plantar fasciitis at some point, with 83% of affected individuals being active working adults aged 25 to 65. Some studies report prevalence rates as high as 22% among runners.

Developments in image-guided interventions, ultrasound-guided injections, and minimally invasive mechanical or sonic therapies improve targeting, reduce recovery time, and enhance efficacy, thus increasing physician and patient adoption. In July 2025, a study published in the American Journal of Physical Medicine & Rehabilitation compared the efficacy of platelet-rich plasma (PRP) and corticosteroids in treating plantar fasciitis. The results indicated that PRP provided superior pain relief and improved foot function over corticosteroid injections. In addition, in July 2025, a study by King George's Medical University researchers in Lucknow explored the effectiveness of ultrasound-guided dextrose prolotherapy versus PRP injections for chronic heel pain. The study found that both treatments significantly reduced pain and improved foot function, with PRP demonstrating slightly superior outcomes.

Global Plantar Fasciitis Treatment Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plantar fasciitis treatment market report based on drug class, disease type, end use, and region:

  • Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others
  • Disease Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Acute Plantar Fasciitis
  • Chronic Plantar Fasciitis
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Disease Type
    • 1.2.3. End Use
    • 1.2.4. Region
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Plantar Fasciitis Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Plantar Fasciitis Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
  • 4.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 4.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Corticosteroids
    • 4.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Others
    • 4.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Plantar Fasciitis Treatment Market: Disease Type Business Analysis

  • 5.1. Disease Type Market Share, 2024 & 2033
  • 5.2. Disease Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Billion)
  • 5.4. Acute Plantar Fasciitis
    • 5.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Chronic Plantar Fasciitis
    • 5.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Others
    • 5.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Plantar Fasciitis Treatment Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2033
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
  • 6.4. Hospitals & Clinics
    • 6.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Others
    • 6.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Plantar Fasciitis Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.4. North America
    • 7.4.1. North America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. Canada Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Europe
    • 7.5.1. Europe Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Brazil Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. Argentina Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Pfizer Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bayer AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Johnson & Johnson
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Viatris Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Teva Pharmaceutical Industries Ltd.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Sanofi
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. AbbVie Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. GSK plc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Novartis AG
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sun Pharmaceutical Industries Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global plantar fasciitis treatment market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 5 Global plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 6 Global plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 7 North America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 8 North America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 9 North America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 10 North America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 11 US plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 12 US plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 13 US plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 14 Canada plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 15 Canada plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 16 Canada plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 17 Mexico plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 18 Mexico plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 19 Mexico plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 20 Europe plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 21 Europe plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 22 Europe plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 23 Europe plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 24 UK plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 25 UK plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 26 UK plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 27 Germany plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 28 Germany plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 29 Germany plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 30 France plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 31 France plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 32 France plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 33 Italy plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 34 Italy plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 35 Italy plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 36 Spain plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 37 Spain plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 38 Spain plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 39 Denmark plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 40 Denmark plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 41 Denmark plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 42 Sweden plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 43 Sweden plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 44 Sweden plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 45 Norway plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 46 Norway plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 47 Norway plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 48 Asia Pacific plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 49 Asia Pacific plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 50 Asia Pacific plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 51 Asia Pacific plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 52 Japan plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 53 Japan plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 54 Japan plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 55 China plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 56 China plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 57 China plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 58 India plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 59 India plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 60 India plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 61 Australia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 62 Australia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 63 Australia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 64 South Korea plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 65 South Korea plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 66 South Korea plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 67 Thailand plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 68 Thailand plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 69 Thailand plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 70 Latin America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 71 Latin America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 72 Latin America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 73 Latin America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 74 Brazil plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 75 Brazil plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 76 Brazil plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 77 Argentina plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 78 Argentina plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 79 Argentina plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 80 Middle East & Africa plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
  • Table 81 Middle East & Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 82 Middle East & Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 83 Middle East & Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 84 South Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 85 South Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 86 South Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 87 Saudi Arabia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 88 Saudi Arabia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 89 Saudi Arabia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 90 UAE plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 91 UAE plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 92 UAE plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
  • Table 93 Kuwait plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
  • Table 94 Kuwait plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
  • Table 95 Kuwait plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Plantar fasciitis treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Billion)
  • Fig. 10 Competitive landscape
  • Fig. 11 Plantar fasciitis treatment market dynamics
  • Fig. 12 Plantar fasciitis treatment market: Porter's five forces analysis
  • Fig. 13 Plantar fasciitis treatment market: PESTLE analysis
  • Fig. 14 Plantar fasciitis treatment market: Drug class movement analysis
  • Fig. 15 Plantar fasciitis treatment market: Drug class outlook and key takeaways
  • Fig. 16 Nonsteroidal anti-inflammatory drugs (NSAIDs) market estimates and forecast, 2021 - 2033
  • Fig. 17 Corticosteroids market estimates and forecast, 2021 - 2033
  • Fig. 18 Others market estimates and forecast, 2021 - 2033
  • Fig. 19 Plantar fasciitis treatment market: Disease type movement analysis
  • Fig. 20 Plantar fasciitis treatment market: Disease type outlook and key takeaways
  • Fig. 21 Acute plantar fasciitis market estimates and forecast, 2021 - 2033
  • Fig. 22 Chronic plantar fasciitis market estimates and forecast, 2021 - 2033
  • Fig. 23 Others market estimates and forecast, 2021 - 2033
  • Fig. 24 Plantar fasciitis treatment market: End use movement analysis
  • Fig. 25 Plantar fasciitis treatment market: End use outlook and key takeaways
  • Fig. 26 Hospitals & clinics market estimates and forecast, 2021 - 2033
  • Fig. 27 Ambulatory surgical centers market estimates and forecast, 2021 - 2033
  • Fig. 28 Others market estimates and forecast, 2021 - 2033
  • Fig. 29 Plantar fasciitis treatment market: Regional movement analysis
  • Fig. 30 Plantar fasciitis treatment market: Regional outlook and key takeaways
  • Fig. 31 North America market estimates and forecast, 2021 - 2033
  • Fig. 32 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 33 Canada market estimates and forecast, 2021 - 2033
  • Fig. 34 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 35 Europe market estimates and forecast, 2021 - 2033
  • Fig. 36 UK market estimates and forecast, 2021 - 2033
  • Fig. 37 Germany market estimates and forecast, 2021 - 2033
  • Fig. 38 France market estimates and forecast, 2021 - 2033
  • Fig. 39 Italy market estimates and forecast, 2021 - 2033
  • Fig. 40 Spain market estimates and forecast, 2021 - 2033
  • Fig. 41 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 42 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 43 Norway market estimates and forecast, 2021 - 2033
  • Fig. 44 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 45 Japan market estimates and forecast, 2021 - 2033
  • Fig. 46 China market estimates and forecast, 2021 - 2033
  • Fig. 47 India market estimates and forecast, 2021 - 2033
  • Fig. 48 Australia market estimates and forecast, 2021 - 2033
  • Fig. 49 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 50 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 51 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 52 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 53 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 54 Middle East & Africa market estimates and forecast, 2021 - 2033
  • Fig. 55 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 56 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 57 UAE market estimates and forecast, 2021 - 2033
  • Fig. 58 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 59 Company categorization
  • Fig. 60 Company market position analysis
  • Fig. 61 Strategic framework